1. Targeting the Mitochondrial Metabolic Network: A Promising Strategy in Cancer Treatment
   Luca Frattaruolo et al, 2020, International Journal of Molecular Sciences CrossRef
2. Doxycycline Hydrochloride Regulates Cytoskeletal Rearrangement and Epithelial-To-Mesenchymal Transition in Malignant Rhabdoid Tumour of the Kidney
   Chenghao Zhanghuang et al, 2022, BioMed Research International CrossRef
3. Transcriptional Expressions of ALDH1A1/B1 as Independent Indicators for the Survival of Thyroid Cancer Patients
   Ying Cui et al, 2022, Frontiers in Oncology CrossRef
4. Drug repurposing—an emerging strategy in cancer therapeutics
   Khadija Shahab Turabi et al, 2022, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
5. A Drug Screening Reveals Minocycline Hydrochloride as a Therapeutic Option to Prevent Breast Cancer Cells Extravasation across the Blood–Brain Barrier
   Joana Godinho-Pereira et al, 2022, Biomedicines CrossRef
6. Novel Therapeutics Against Breast Cancer Stem Cells by Targeting Surface Markers and Signaling Pathways
   Plabon K. Das et al, 2019, Current Stem Cell Research & Therapy CrossRef
7. Interplay between Mitochondrial Metabolism and Cellular Redox State Dictates Cancer Cell Survival
   Brittney Joy-Anne Foo et al, 2021, Oxidative Medicine and Cellular Longevity CrossRef
8. Doxycycline, an Inhibitor of Mitochondrial Biogenesis, Effectively Reduces Cancer Stem Cells (CSCs) in Early Breast Cancer Patients: A Clinical Pilot Study
   Cristian Scatena et al, 2018, Frontiers in Oncology CrossRef
9. A Myristoyl Amide Derivative of Doxycycline Potently Targets Cancer Stem Cells (CSCs) and Prevents Spontaneous Metastasis, Without Retaining Antibiotic Activity
   Béla Ózsvári et al, 2020, Frontiers in Oncology CrossRef
10. Role of Mitochondria in Cancer Stem Cell Resistance
    José Manuel García-Heredia et al, 2020, Cells CrossRef
11. Repurposing Drugs as Novel Triple-negative Breast Cancer Therapeutics
    Amiya Das et al, 2022, Anti-Cancer Agents in Medicinal Chemistry CrossRef